MET097 for obesity

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 19 Dec 2025: Trial started, NCT07311850
  2. 31 Dec 2025: Trial registered, NCT07311850

The trials

NCT07311850: Efficacy and Safety of MET097 Once-Weekly in People With Overweight or Obesity

State
Under way
Phase
Phase 3
People
3,578 taking part
Started
19 Dec 2025
Primary completion
21 Sep 2027
Arms
MET097 Dose 1, MET097 Dose 2, MET097 Dose 3
Results
None posted
  1. 19 Dec 2025: Trial started
  2. 31 Dec 2025: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.